Sahpra examines side effects related to Johnson & Johnson’s Covid-19 vaccine

The South African Health Products Regulatory Authority (SAHPRA) has yet to clarify the details on the side effects related to the Johnson and Johnson Covid-19 vaccine.

Researchers with the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention in the United States found that the vaccine resulted in 60 confirmed cases of thrombosis with thrombocytopenia syndrome.

This leads to rare but potentially life-threatening blood clots, the FDA said, a week or two after receiving the injection.

With more vaccines available, the FDA has decided to bench the J&J vaccine, to be used only when other options are unavailable.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the institute recognizes that the Janssen Covid-19 vaccine still plays a role in the current pandemic response in the United States and the global community.

“Our action reflects our updated risk analysis of TTS after administration of this vaccine and limits the use of the vaccine to certain individuals. We closely monitored the Janssen Covid-19 vaccine and the onset of TTS after its administration. and we used updated information from our security surveillance systems to review the EUA. ”

“The agency will continue to monitor the safety of the Janssen COVID-19 vaccine and all other vaccines and, as was the case during the pandemic, will thoroughly evaluate the new safety information,” said Mark.

Trying to get clarity on the severity of the side effects, The citizen contacted the National Department of Health e Will know regarding the impact and who could potentially be at risk.

Although the health department did not answer the question, Sahpra spokesman Yuven Gounden said they are investigating.

“Sahpra is reviewing the information reported by the FDA along with AEFI reports received locally and will soon release a statement to the media to advise on the way forward. More than 18.7 million doses of the J&J vaccine have been administered in the United States since it was first approved for emergency use, the Centers for Disease Control and Prevention reported. Of which a total of 60 cases of TTS have been confirmed, including nine deaths.

READ ALSO: Calls to vaccinate as SA approaches record highest Covid-19 positivity rates